Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study
JNCI: Journal of the National Cancer Institute · 01.04.2025 · 117 (4) · 653-664
DOI: 10.1093/jnci/djae287 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 12.11.2024. Verfasst von Maya Aboumrad und 2 weiteren Autor:innen. Beteiligte Einrichtung: White River Junction VA Medical Center, White River Junction, VT 05009, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Major Depressive Disorder, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Breast Cancer Research Foundation.
Abstract (Originalsprache)
Background
Establishing whether women with major depressive disorder who develop breast cancer have poor outcomes is key to optimizing care for this population. To this end, we examined associations between major depressive disorder and breast cancer recurrence and mortality.
Methods
Using medical record data from the US Department of Veterans Affairs health-care system, we established a retrospective cohort of women with local or regional stage invasive breast cancer between 2010 and 2019 and followed them through 2022. We used a 2-year window to identify women diagnosed with major depressive disorder before breast cancer diagnosis. We used multivariable Cox-proportional hazards regression to estimate associations between major depressive disorder and breast cancer recurrence and mortality while accounting for competing risks and adjusting for sociodemographic, clinical, lifestyle, and tumor characteristics.
Results
We identified 6051 women with breast cancer, of whom 1754 (29%) had major depressive disorder. The mean (SD) age at breast cancer diagnosis was 57 (11) years. In multivariable analyses, women with major depressive disorder had a 37% (hazard ratio = 1.37, 95% CI = 1.19 to 1.57) higher risk of recurrence and a 30% (hazard ratio = 1.30, 95% CI = 1.02 to 1.64) higher risk of breast cancer mortality. The association between major depressive disorder and recurrence was stronger among women with estrogen receptor–positive breast cancer. In secondary analyses, there were statistically significant interactions between major depressive disorder and multiple exposures with respect to recurrence, including current smoking, substance abuse, and nonreceipt of screening mammography.
Conclusions
Women with major depressive disorder had inferior breast cancer outcomes compared with women without a history of major depressive disorder. Research is needed to investigate underlying mechanisms linking depression to breast cancer progression and evaluate interventions to improve outcomes in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- White River Junction VA Medical Center, White River Junction, VT 05009, United States.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States.
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21205, United States.
ORCID-Profile: Maya Aboumrad, Corinne Joshu, Kala Visvanathan
Förderung
- NCI NIH HHS
- NIH HHS
- Breast Cancer Research Foundation
- NCRR NIH HHS
- VA Medical Centers
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Aboumrad, M., Joshu, C., & Visvanathan, K. (2025). Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study. JNCI: Journal of the National Cancer Institute, 117(4), 653-664. https://doi.org/10.1093/jnci/djae287
Vancouver
Aboumrad M, Joshu C, Visvanathan K. Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study. JNCI: Journal of the National Cancer Institute. 2025;117(4):653-664. doi:10.1093/jnci/djae287
BibTeX
@article{Aboumrad2025,
author = {Aboumrad, Maya and Joshu, Corinne and Visvanathan, Kala},
title = {Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
volume = {117},
number = {4},
pages = {653--664},
doi = {10.1093/jnci/djae287}
}
EUVIMED